OVID Q1 2026 Earnings Narrower Loss and No Revenue Mark a Quiet Quarter for the Biotech DYAI Q1 2026 Earnings EPS Misses Mark as PreRevenue Biotech Maintains Pipeline Focus ALGT Q1 2026 Earnings Solid EPS Beat Masks Revenue Concerns as Shares Slip Annovis Bio ANVS Q1 2026 Earnings EPS Miss Widens as Pipeline Costs Mount Stock Declines Lee Enterprises Q1 2026 Earnings EPS Outperformes Estimates by a Wide Margin Amid Ongoing Digital Transition Blue Owl Capital Corporation OBDC Q1 2026 Earnings EPS Misses Estimates Despite Upbeat Stock Reaction